News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
Oestrogen-suppressing drugs substantially reduce breast cancer deaths

23/07/15

A class of hormonal drugs – already used in the clinic – reduce the risk of death in postmenopausal women with the most common type of breast cancer.
lung MRI
New ‘chemotherapy booster’ could treat lung and pancreatic cancer

23/07/15

A new drug that blocks cancer’s escape route from chemotherapy could be used to treat deadly lung and pancreatic cancers, new research reports.
Breast cancer cells (green) invading through a layer of fibroblasts (red). (Luke Henry / the ICR, 2009)
Resistance to cancer drug found to occur naturally in the breast

22/07/15

Study finds the genetic mutations which drive resistance to some targeted cancer drugs are present in breast cancer cells right from the beginning of treatment.
Chemical Probes Portal
New ‘TripAdvisor’ site to address use of substandard biomedical research tools

21/07/15

A new 'TripAdvisor-style' website will help biomedical researchers pick the best chemical probes for the job – improving research and treatment of disease.
DNA sequence_547x410
Word processing for mankind

13/07/15

In the third of five articles short-listed for the ICR's Mel Greaves Science Writing Prize 2015, Kevin Litchfield discusses the potential consequences of cutting-edge genetics research.
ICR Logo
Professor Stan Kaye honoured with students at annual awards

09/07/15

Professor Stan Kaye, a pioneer in experimental clinical trials world-class translational research, was honoured alongside students and former staff members at our annual celebration, the ICR Awards Ceremony.
Cell cultures incubating
Plan your child’s future – because you never know when sci-fi becomes true

08/07/15

In the second of five articles short-listed for the ICR's Mel Greaves Science Writing Prize 2015, Marcia Costa delves into the science and ethics behind many of science fiction's greatest stem-cell inventions.
ICR Logo
ICR gala fundraising dinner raises £250,000 for research into cancer

06/07/15

Gala fundraising event raises an impressive £250,000 for the ICR’s cancer research.
ICR Logo
Scientists advance cancer drug design with image of one of key proteins of life

02/07/15

Scientists have pioneered the use of a high-powered imaging technique to picture in exquisite detail one of the central proteins of life – a cellular recycling unit with a role in many diseases.
Removing protein slows blood vessel growth in tumours

01/07/15

Scientists from the University of Leeds and The Institute of Cancer Research, London, have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain, a common location which breast cancer can spread to.
ICR Logo
Re-inventing the finger

29/06/15

In the first of five articles short-listed for the ICR's Mel Greaves Science Writing Prize 2015, the winner Dr Hugh Harvey writes about re-inventing an age-old test for prostate cancer.
Radiotherapy machine at The Royal Marsden Hospital
New radiotherapy technique could target prostate cancer while reducing side-effects

25/06/15

A new technique for targeting radiotherapy at prostate cancer could improve treatment for aggressive disease that has spread into pelvic lymph nodes.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.